2. UroToday Home
  3. Video Lectures

Upper Tract Urothelial Carcinoma Videos

ECOG-ACRIN 8192 Evaluates Preoperative Gemcitabine Plus Durvalumab in Cisplatin-Ineligible UTUC - Jeannie Hoffman-Censits
Multi-Center Study Examines Protein Biomarkers in Upper Tract Cancer Detection - Jennifer Linehan
ASCO GU 2026 Preview: Trials in Bladder and Upper Tract Cancer - Petros Grivas
A Split-Function Approach to Estimate Post-Surgical Kidney Health in Upper Tract Urothelial Carcinoma - Kieran Lewis
Vascular-Targeted Photodynamic Therapy in the Phase III ENLIGHTED Trial for UTUC - Ali Zahalka
Non-Urothelial Recurrence Patterns After Nephroureterectomy for Upper Tract Cancer - Andrew Katims
Multiplex Urine Protein Assay Performance in a Real-World Multi-Center Clinical Setting - Hideki Furuya
Endoscopic Management Score Guides Decision-Making for Upper Tract Tumors - Suzanne Lange
Adjuvant vs Neoadjuvant Chemotherapy Debate for Upper Tract Urothelial Carcinoma - Morgan Rouprêt & Alison Birtle
UGN-101 Shows Durable Long-Term Efficacy for Low-Grade Upper Tract Urothelial Cancer - Phillip Pierorazio
Complete Response in Low-Grade UTUC with Padeliporfin Therapy in the ENLIGHTED Trial - Vitaly Margulis
Comparing Therapy Approaches for Advanced Upper Tract Urothelial Carcinoma - Joon Kyung Kim
Mucoadhesive Gemcitabine Formulation for Upper Tract Urothelial Carcinoma - Marie-Pier St-Laurent
Validation of Keratin 17 as a Sensitive Marker for Upper Tract Urothelial Cancer - Woodson Smelser
Study Shows Bladder Cuff Excision Improves Recurrence-Free Survival After Nephroureterectomy - Courtney Yong & Chandru Sundaram
UGN-101 in Upper Tract Urothelial Cancer: Real-World Data Analysis - Joseph Jacob
Early Bladder Recurrence Common in UTUC Patients Post-Nephroureterectomy Despite BCG Treatment - Paul Crispen
FGFR3 Inhibition for Upper Tract Urothelial Cancer: Phase 1b Trial Results - Surena Matin
ENLIGHTED Trial Advances Upper Tract Urothelial Cancer Treatment - Vitaly Margulis
Advancing UTUC Diagnosis: Protein-Based Biomarker Test Outperforms Cytology - Hideki Furuya
POUT Trial: Final Results of Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma - Alison Birtle
Predictive Biomarkers for Upper Tract Urothelial Carcinoma - Helen Hougen
Route of Administration for UGN-101 and the Impact on Oncological & Safety Outcomes - Jennifer Linehan
What Every Urologist Should Know About UGN-101 Treatment and its Real-World Implications for Urothelial Cancer - Hristos Kaimakliotis
Guidelines and Real-World Scenarios in Upper Tract Urothelial Carcinoma Treatment - Kyle Rose
Management of Low-Grade Upper Tract Urothelial Carcinoma: Case-Based Presentation - Rashid Sayyid
Comprehensive Geriatric Assessments in Urologic Cancer Care: Identifying Modifiable Risk Factors for Personalized Treatment - Sarah Psutka
Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma - Wesley Yip and Jonathan Coleman
Results from the Radical Nephroureterectomy Outcomes (RaNeO) Registry - Clara Cerrato
Establishing a Workable Treatment Algorithm for JELMYTO® for Low-Grade Upper Tract Urothelial Carcinoma- Amy Luckenbaugh
AUA Guidelines for Upper Tract Urothelial Carcinoma: Streamlined Approaches and Novel Opportunities for Treatment - Jean Heather Hoffman-Censits
Insights into the AUA Guidelines for Upper Tract Urothelial Carcinoma: Standardizing Diagnosis and Treatment for Better Patient Outcomes - Jonathan A. Coleman
Expert Panel Discussion on Management of UTUC: Insights on Treatment, Prevention, and Future Directions - Surena Matin, Jay Raman, Sima Porten, and Tomonori Habuchi
DNA Methylation Urine Biomarkers Test Shows Promise in Diagnosing Upper Tract Urothelial Cancer - Angelo Territo & Andrea Gallioli
Neoadjuvant Versus Adjuvant Chemotherapy in Patients With Clinically Node-positive UTUC Who Underwent a Radical Nephroureterectomy - Karan Jatwani
The Role of Adjuvant Chemotherapy, Versus Observation, in Patients With Upper Urinary Tracts With Variant Histology Undergoing a Radical Nephroureterectomy - Karan Jatwani
Clinicopathological or Radiological Factors That May Predict a Diagnosis of Upper Urinary Tract Urothelial Cell Carcinoma Without the Delay for Diagnostic Ureteroscopy - Alexander Laird
Neoadjuvant Nivolumab and Ipilimumab for Upper Tract Urothelial Cancer - Min Yuen Teo
The Impact of a Neoadjuvant Chemotherapy Treatment Prior to Radical Nephroureterectomy for Patients with High-Grade Upper Tract Urothelial Carcinoma - Jonathan Coleman & Wesley Yip
A SEER-Medicare Based Quality Score for Patients with Both Synchronous and Metachronous Metastatic Upper Tract Urothelial Carcinoma - Daniel Joyce
The Impact and Evaluation of Lynch Syndrome on Upper Tract Urothelial Carcinoma - Marco Moschini
Upper Tract Urothelial Cancers An EAU Guidelines Discussion - Paolo Gontero
Treatment Patterns, Outcomes, and Costs Associated With the Management of Low- and High-Risk UTUC - Katherine Fero & Stephen Williams
Game-Changing Trial Targets Immunotherapy for UTUC - Woodson Smelser
Charting New Paths in Urothelial Cancer Treatment: the ECOG-ACRIN 8192 Trial - Jean Hoffman-Censits
Laser Technologies in Focus: Advancing Upper Tract Tumor Management - Silvia Proietti
Longitudinal GFR Trends After Neoadjuvant Chemotherapy Prior to Nephroureterectomy for Upper Tract Urothelial Carcinoma - Surena Matin & Craig Labbate
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical Chemo for UTUC - Francesco Del Giudice & Ben Chung
Practice Changing Abstracts in Upper Tract Urothelial Carcinoma, A Review from the 2022 AUA - Firas Petros
A Multidisciplinary Approach to Treating High-Grade Upper Tract Disease - A Case-Based Approach - Surena Matin, Jonathan Coleman, and Jean Hoffman-Censits
Antegrade Administration of Reverse Thermal Mitomycin Gel for Primary Chemoablation of Upper Tract Urothelial Carcinoma via Percutaneous Nephrostomy Tube - Katie Murray
Evaluating the Impact of Variant Histology Pathologic Diagnosis on Survival Outcomes in Patients with Upper Tract Urothelial Carcinoma - Wesley Yip
Upper Tract Urothelial Carcinoma Highlights - Nima Almassi
Adjuvant Therapy after Nephroureterectomy for High-Risk Upper Tract Urothelial Carcinoma - Sima Porten
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101 in the OLYMPUS Trial - John Gore
Comparative Effectiveness of Neoadjuvant Chemotherapy In Bladder And Upper Urinary Tract Urothelial Carcinoma - Jeffrey Holzbeierlein
Preventing Recurrence of Urothelial Carcinoma in Patients with Upper Tract Carcinoma - Aditya Bagrodia
Real-World Experience on the Safety Efficacy of Antegrade Administration of JELMYTO® for UTUC via Percutaneous Nephrostomy Tube - Kyle Rose
A Growing Understanding and Multidisciplinary Approach to Treating Upper Tract Urothelial Carcinoma - Jeannie Hoffman-Censits
The Role of ctDNA in Metastatic Urothelial Cancer - Alexander Wyatt
Long-Term Safety and Durability to Non-Surgical Treatment Instillation of UGN-101, Mitomycin-Containing Reverse Thermal Gel for Low-Grade Upper Tract Urothelial Carcinoma, Journal Club - Zachary Klaassen and Christopher Wallis
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients with High-Grade Upper Tract Urothelial Carcinoma - Wesley Yip
Endoscopy in the Setting of Low-Grade Upper Tract Urothelial Carcinoma A Lecture and Discussion - Surena Matin
Molecular Biomarkers in Upper-Tract Urothelial Carcinoma - Janet Kukreja
How I Treat Low-Risk Upper Tract Urothelial Carcinoma - Katie Murray
Radical Nephroureterectomy in Upper Tract Urothelial Cancer - Phillip Pierorazio
Antegrade Endoscopic Upper Tract Approaches - Ryan Hsi
Upper Tract Urothelial Carcinoma - Clinical Case Management in High-Risk Disease - Sima Porten
The POUT Trial's Impact on Upper Tract Urothelial Carcinoma: A Deep Dive into Adjuvant Chemotherapy - Evanguelos Xylinas
Upper Tract Urothelial Carcinoma - Clinical Case Management in Low-Risk Disease - Vitaly Margulis
Risk Stratification of Upper Tract Urothelial Carcinoma - Doug Scherr
Genetics in Upper Tract Urothelial Cancer, What Urologists Should Know – Eugene J. Pietzak
Management and Challenges of Low Grade Upper Tract Urothelial Carcinoma - Surena Matin
Treatment Considerations for Upper Tract Urothelial Carcinoma - Eugene Pietzak and Arjun Balar
How I Use Jelmyto™ - Karim Chamie
Upper Tract Urothelial Carcinoma - Clinical Case Management – Jonathan Coleman
The Genomic and Transcriptomic Landscape of UTUC: Implications for Targeted Therapies - Bishoy Faltas
The Potential of Breakthrough Trials in Urothelial Carcinoma: ECOG-ACRIN 8192 - Petros Grivas
Primary Chemoablation for the Treatment of Low-Grade Upper Tract Urothelial Carcinoma: The OLYMPUS Trial - Seth Lerner
Lancet Oncology OLYMPUS Trial Review: Primary Chemoablation for the Treatment of Low Grade Upper Tract Urothelial Carcinoma
Developments in Treatment Options for Localized and Advanced Upper Tract Disease - Vitaly Margulis
The OLYMPUS Study: Mitomycin Gel for Low-grade Upper Tract Urothelial Cancer - Seth Lerner
Moving the Field Forward, Upper Tract Urothelial Carcinoma, The POUT Study - Alison Birtle
Biology and Genomic Distinctions in Metastatic Urothelial Carcinoma and Upper Tract Urothelial Cancers - Andrew Hsieh - Bishoy Faltas - Matthew Galsky
Challenges in the Diagnosis and Treatment of UTUC - Peter Black
SAUL Trial Data: Real World Experience of Atezolizumab in Carcinomas of the Urinary Tract- Cora Sternberg
Challenges in Immunotherapy for Bladder Cancer- Maria De Santis
Systemic Therapies in Upper Tract Urothelial Carcinoma - Srikala Sridhar
The Diagnostic and Therapeutic Challenges Associated with UTUC - Sam Chang